Skip to main content
Premium Trial:

Request an Annual Quote

UW Purchases Site License for Spotfire s DecisionSite Software

NEW YORK, May 19 - Spotfire said today that the University of Washington has purchased a site-wide license for its DecisionSite analytical software.


UW has integrated Spotfire's software with its in-house gene array database and analysis system, the company said. The system combines both internal and external proteomics and microarray data for UW's microbiology research.


Financial terms of the deal were not provided.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.